Cresco Labs Inc. (OTCMKTS:CRLBF – Get Free Report)’s share price reached a new 52-week low on Wednesday . The stock traded as low as $1.09 and last traded at $1.15, with a volume of 3057329 shares trading hands. The stock had previously closed at $1.52.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on the stock. Roth Capital raised shares of Cresco Labs from a “hold” rating to a “strong-buy” rating in a research note on Friday, August 9th. Needham & Company LLC reissued a “hold” rating on shares of Cresco Labs in a research report on Monday, August 12th. Finally, Ventum Cap Mkts raised Cresco Labs to a “strong-buy” rating in a research report on Friday, August 9th. Two research analysts have rated the stock with a hold rating, two have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, Cresco Labs currently has a consensus rating of “Buy” and an average price target of $2.50.
View Our Latest Analysis on Cresco Labs
Cresco Labs Stock Down 24.7 %
Cresco Labs (OTCMKTS:CRLBF – Get Free Report) last released its earnings results on Thursday, August 8th. The company reported ($0.16) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.15). The firm had revenue of $184.36 million for the quarter, compared to analyst estimates of $184.26 million. Cresco Labs had a negative return on equity of 17.03% and a negative net margin of 23.07%. Analysts expect that Cresco Labs Inc. will post -0.15 EPS for the current year.
About Cresco Labs
Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.
Featured Stories
- Five stocks we like better than Cresco Labs
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- What a Trump Win Looks Like for the Market Now and Into 2025
- Are Penny Stocks a Good Fit for Your Portfolio?
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- What Are Dividend Champions? How to Invest in the Champions
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.